SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

SPDR S&P 500 ETF TRUST - SPDR S&P 500 ETF Trust

The S&P 500 ETF is seeing extreme volatility as market sentiment shifts rapidly between optimism over a potential Iran ceasefire deal and intense liquidity concerns surrounding the upcoming SpaceX IPO. Investors are actively debating the sustainability of current price levels, with many traders cautioning against complacency while others aggressively play both sides of the sharp intraday swings.

Applied Digital Corp. is a technology company, which engages in the provision of development and operation of data centers which provide computing power. It operates through the Data Center Hosting Business and HPC Hosting Business segments. The Data Center Hosting Business segment provides energized infrastructure services to crypto mining customers. The HPC Hosting Business segment focuses on the designing, constructing, and operating data centers tailored to support high power density applications like HPC and AI. The company was founded by Wesley Carl Cummins and Jason Zhang in May 2001 and is headquartered in Dallas, TX.

Applied Digital Corporation

Applied Digital is trending following the announcement of a new $5.2 billion, 15-year AI data center lease at its fifth campus, an event that has spurred bullish analyst upgrades and renewed investor confidence. The community is actively debating the stock's significant contracted revenue backlog against broader market volatility and algorithmic trading patterns, with many long-term holders viewing current price fluctuations as accumulation opportunities ahead of a potential re-rating.

Invesco QQQ Trust Series 1 - Invesco QQQ Trust Series 1

The Invesco QQQ Trust is experiencing significant volatility as investors weigh a wave of high-profile AI-related IPOs against broader market concerns regarding inflation and geopolitical uncertainty. The community is actively debating whether current price action represents a healthy consolidation or a warning sign of a potential liquidity crunch as capital rotates in anticipation of upcoming mega-cap public debuts.

iShares Trust - iShares Russell 2000 Index Fund

iShares Russell 2000 ETF

The Russell 2000 is facing significant volatility as investors monitor heightened tensions in the Middle East and shifting Federal Reserve rate expectations. Community sentiment is currently split between those anticipating a tactical pullback due to inflationary pressures and others betting on a breakout as small-cap valuations potentially benefit from an eventual market rotation.

Capricor Therapeutics, Inc. is a clinical-stage biotechnology company, which focuses on the development of transformative cell and exosome-based therapeutics for treating Duchenne muscular dystrophy (“DMD”), a rare form of muscular dystrophy which results in muscle degeneration and premature death, and other diseases with unmet medical needs. Its product candidate consists of CAP-1002, Engineered Exosomes, CAP-2003, and Exosome-Based Vaccine. The company was founded on June 17, 1996 and is headquartered in San Diego, CA.

Capricor Therapeutics Inc

Capricor Therapeutics is trending as investors weigh the potential impact of a legal dispute with Nippon Shinyaku against the upcoming PDUFA catalyst for Deramiocel. The community remains largely bullish, focusing on institutional accumulation and the potential for a favorable court resolution to allow for independent commercialization.

Apple, Inc. engages in the design, manufacture, and sale of smartphones, personal computers, tablets, wearables and accessories, and other varieties of related services. It operates through the following geographical segments: Americas, Europe, Greater China, Japan, and Rest of Asia Pacific. The Americas segment includes North and South America. The Europe segment consists of European countries, as well as India, the Middle East, and Africa. The Greater China segment comprises China, Hong Kong, and Taiwan. The Rest of Asia Pacific segment includes Australia and Asian countries. Its products and services include iPhone, Mac, iPad, AirPods, Apple TV, Apple Watch, Beats products, AppleCare, iCloud, digital content stores, streaming, and licensing services. The company was founded by Steven Paul Jobs, Ronald Gerald Wayne, and Stephen G. Wozniak in April 1976 and is headquartered in Cupertino, CA.

Apple Inc

Apple is experiencing a sharp decline as investors respond to an underwhelming WWDC presentation, with many community members questioning the company's innovation and its heavy reliance on third-party AI models. While some long-term investors see the pullback as a buying opportunity, others are aggressively rotating into bearish positions, citing the stock's elevated valuation and the lack of a clear, immediate revenue catalyst from the new AI features.

Rivian Automotive, Inc. engages in the design, development, and manufacture of category-defining electric vehicles and accessories. It operates through following segments: Automotive, Software and Services. The company was founded by Robert J. Scaringe in June 2009 and is headquartered in Irvine, CA.

Rivian Automotive Inc - Ordinary Shares - Class A

Rivian Automotive Inc

Rivian Automotive is trending as investors focus on the public delivery launch of the R2 SUV, which serves as a major catalyst for the company's production and growth strategy. While the community is actively debating the stock's long-term potential versus short-term price volatility, sentiment is split between optimism over product demand and skepticism regarding the company's path to profitability.

Zevra Therapeutics, Inc. is a commercial-stage rare disease company that combines science, data and patient needs to create therapies for diseases with limited or no treatment options. The firm focuses on the treatment of rare neurological and sleep conditions such as certain Urea Cycle Disorders, Niemann Pick Disease Type C and Idiopathic Hypersomnia. The company receives royalties for AZSTARYS from its commercial partner Corium. The company was founded by Christal M. M. Mickle and Travis C. Mickle on October 30, 2006 and is headquartered in Celebration, FL.

Zevra Therapeutics Inc

Zevra Therapeutics is trending as investors show optimism leading into earnings, fueled by robust revenue growth, a strong cash position, and institutional accumulation from firms like Fidelity. The community is actively debating the impact of upcoming catalysts, including potential patent extensions for Miplyffa and EU regulatory progress, while closely monitoring management's ability to drive patient enrollment and long-term valuation.

Direxion Shares ETF Trust - Direxion Daily Semiconductor Bull 3X ETF

Direxion Daily Semiconductor Bull 3X Shares

Direxion Daily Semiconductor Bull 3X Shares (SOXL) is facing extreme volatility as investors react to a sharp pullback in the semiconductor sector, fueled by concerns over AI-related capital expenditures and broader market liquidity shifts. The community is heavily divided, with many traders debating whether this steep decline represents a healthy buying opportunity for a bounce or the initial stages of a major bubble correction.

Microsoft Corp. engages in the development and support of software, services, devices, and solutions. It operates through the following segments: Productivity and Business Processes, Intelligent Cloud, and More Personal Computing. The Productivity and Business Processes segment is composed of products and services relating to productivity, communication, and information services such as Office Commercial, Office Consumer, LinkedIn, and Dynamics business solutions. The Intelligent Cloud segment consists of public, private, and hybrid server products and cloud services for businesses and developers, as well as enterprise and partner services. The More Personal Computing segment refers to products and services including Windows operating system, Windows cloud services, Surface, HoloLens, personal computer accessories, Xbox hardware, Xbox Cloud Gaming, Microsoft News, and Microsoft Edge. The company was founded by Paul Gardner Allen and William Henry Gates, III in 1975 and is headquartered in Redmond, WA.

Microsoft Corporation

Microsoft Corp

Microsoft is facing intense downward pressure and negative investor sentiment, with community members actively discussing a potential breakdown toward support levels as the stock struggles to maintain momentum despite its AI sector positioning. Investors are expressing deep frustration over the recent price volatility and are debating whether the stock represents a long-term value opportunity or a deteriorating asset following recent failed rallies.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Cardio Diagnostics Holdings (NASDAQ: CDIO) Showcases AI-Powered Cardiovascular Risk Solutions at Four National Benefits Conferences

Cardio Diagnostics Holdings (NASDAQ: CDIO)&#160;announced it will exhibit at four national benefits conferences in June to engage employers, brokers, union trustees and plan administrators on strategies to address cardiovascular disease, a leading driver of health plan costs and workforce productivity losses. The company will showcase its AI-powered cardiovascular risk assessment offerings, including Epi+Gen CHD(TM), PrecisionCHD(TM) [&#8230;]

Cardio Diagnostics Holdings, Inc. to Showcase Precision Cardiovascular Solutions at Four National Benefits Conferences in June

Cardio Diagnostics Holdings, Inc. (Nasdaq: CDIO), an AI-powered precision cardiovascular medicine company, today announced that the company will exhibit at four upcoming national benefits conferences, connecting with employers, brokers, union trustees, and plan administrators on a shared challenge...

Cardio Diagnostics Holdings (NASDAQ: CDIO) CEO Highlights Growth Strategy, India Expansion on BioMedWire Podcast

Cardio Diagnostics Holdings (NASDAQ: CDIO),&#160;took the spotlight in the latest episode of The&#160;BioMedWire&#160;Podcast, featuring CEO and Co-Founder Dr. Meesha Dogan discussing the company’s mission to improve cardiovascular disease prevention and early detection through precision medicine powered by epigenetics,&#160;genetics&#160;and artificial intelligence. During the interview, Dogan also highlighted Cardio Diagnostics’ expansion into India through partnerships with Aimil [&#8230;]

Cardio Diagnostics Holdings (NASDAQ: CDIO) Focused on Vision for Personalized Heart Care

Heart disease remains the leading cause of death worldwide, yet much of modern healthcare still focuses on reacting to cardiovascular events after they occur rather than identifying risk earlier and preventing disease progression.&#160;Cardio Diagnostics Holdings (NASDAQ: CDIO)&#160;is working to help reshape that paradigm through a vision centered on personalized, data-driven cardiovascular care powered by artificial [&#8230;]

Cardio Diagnostics Holdings (NASDAQ: CDIO) Advancing Early Detection, Tackling Heart Disease Through AI and Biomarker Insights

Cardiovascular disease continues to place a profound burden on individuals, economies and healthcare systems worldwide, affecting millions of lives while driving substantial medical costs and resource demands.&#160;Cardio Diagnostics Holdings (NASDAQ: CDIO)&#160;is committed to reducing the impact of heart disease by developing a platform that integrates artificial intelligence and epigenetic and genetic biomarkers to deliver personalized [&#8230;]

Cardio Diagnostics Holdings (NASDAQ: CDIO) Advancing AI Solutions for Cardiovascular Disease Detection and Management

Cardiovascular disease remains one of the most serious and costly health challenges worldwide, driving an urgent need for earlier detection and more precise, personalized treatment strategies.&#160;Cardio Diagnostics Holdings (NASDAQ: CDIO)&#160;is focused on addressing this need by developing advanced solutions that leverage artificial intelligence (“AI”) and multi-omic biomarkers to deliver actionable insights from a simple blood [&#8230;]

Cardio Diagnostics Holdings, Inc. to Host Investor Call on Wednesday, February 18, 2026

Cardio Diagnostics Holdings, Inc. (Nasdaq: CDIO) (Cardio Diagnostics or the Company), a precision cardiovascular medicine company leveraging epigenetics, genetics, and artificial intelligence for the...

Cardio Diagnostics, Aimil Ltd. and Dr. Lal PathLabs Limited Partner to Launch the PrecisionCHD Test in India

Cardio Diagnostics Holdings, Inc. (NASDAQ: CDIO), a leader in epigenetics and AI-driven Precision Cardiovascular Medicine, Aimil Ltd., a company at the forefront of the instrumentation industry in...

Cardio Diagnostics Holdings, Inc. and Southdale YMCA Announce New Heart Health Partnership to Serve the Edina, Minnesota Community

Cardio Diagnostics Holdings, Inc. (Nasdaq: CDIO), an AI-powered precision cardiovascular medicine company, today announced a new partnership with the Southdale YMCA to bring expanded heart health...

Cardio Diagnostics Holdings, Inc. to Present Data Demonstrating PrecisionCHDs Ability to Detect INOCA and MINOCA at the American Heart Association Scientific Sessions

Cardio Diagnostics Holdings, Inc. (Nasdaq: CDIO), an AI-powered Precision Cardiovascular Medicine company, today announced that the Company will be presenting new data at the American Heart...

Cardio Diagnostics Holdings, Inc. engages in the provision of medical diagnostic testing services. It also develops and commercializes a series of products for major types of cardiovascular disease and associated co-morbidities including coronary heart disease (CHD), stroke, heart failure, and diabetes. The company was founded in 2007, and is headquartered in Chicago, IL.

Current Price	$1.86
Prev Close	$1.99
Open	$2.03
Dividend Yield	0.00%
50-Day Moving Average	$1.85
Beta	2.11
Avg. Volume	79,470.55
PE Ratio	-0.59

52-Week High	$7.91
52-Week Low	$0.97
Market Capitalization	$5.89M
EPS (Annual)	-$3.71
Price to Book	0.66
Revenue Per Employee	$988.33

CDIOCardio Diagnostics Holdings Inc

Fundamentals

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest CDIO News